was named chair of the U.S. Preventive Services Task Force and was elected to the Association of American Physicians.
- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Departments||Type of Faculty|
|Health Policy and Management||Part Time|
Carol M. Mangione, M.D., M.S.P.H., F.A.C.P. is the Division Chief of General Internal Medicine and Health Services Research and Professor of Medicine and Public Health. She holds the Barbara A. Levey, MD, and Gerald S. Levey, MD, endowed chair in medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and is professor at the UCLA Fielding School of Public Health. She serves as co-director of the UCLA Resource Center for Minority Aging Research/Center for Health Improvement of Minority Elderly, associate director of the UCLA Clinical and Translational Sciences Institute (CTSI), and director of the UCLA CTSI Workforce Development Program. She is also a practicing primary care physician in the UCLA Faculty Practice Group. Dr. Mangione’s areas of expertise include diabetes, diabetes prevention, health disparities, aging, health insurance benefit design, preventive services, and public health policy. She serves as the national study co-chair for the multicenter program Natural Experiments in Translation for Diabetes, which is sponsored by the Centers for Disease Control and Prevention (CDC), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), and the Patient-Centered Outcomes Research Institute, and also serves as a member of the Board of Governors for the Pardee RAND Graduate School. Dr. Mangione is a member of the U.S. Preventive Services Task Force.
Dr. Mangione is the academic director of the “UCMYRx Program,” which embeds clinical pharmacists in primary care practices to enhance communication, educate, and improve medication adherence for patients with poor control of cardiovascular risk factors and for older adults who have polypharmacy and are struggling with adherence to their medications. She is co-principal investigator of a grant from NIDDK, “A Cluster-Randomized Trial of Pharmacist-Coordinated Implementation of the Diabetes Prevention Program,” which evaluates a primary care–based program that uses a shared decision making tool to help patients with prediabetes learn about the condition and make treatment choices that will reduce their chance of developing diabetes. She is also co-PI for the CDC and NIDDK award entitled “A Partnered Evaluation of United Health Care’s Medicaid Plan Innovations for Diabetes Patients,” which is evaluating health plan–level innovations designed to improve the care of patients with chronic conditions in the Medicaid population. Most recently, she became the co-principal investigator of a grant awarded from PCORI, “Using Personalized Risk/Benefit Profiles in SDM for Diabetes Prevention,” which will study the implementation of Shared Decision Making for diabetes prevention and derive insights to guide sustainability and promote future dissemination.
Dr. Mangione is the 2018 recipient of the John M. Eisenberg National Award for Career Achievement in Research from the Society for General Internal Medicine (SGIM), was also recognized in 2013 with the UCLA Exceptional Physician Award and in 2005 with the Society of General Internal Medicine Mid-Career Mentorship Award. Dr. Mangione has authored more than 300 peer-reviewed articles and seven book chapters. In 2019, she was elected to the National Academy of Medicine.
Dr. Mangione received her B.S. from the University of Michigan, Ann Arbor. She earned her M.D. at the University of California, San Francisco, and completed her residency and chief residency at University of California Affiliated Hospitals. Dr. Mangione earned her M.S.P.H. from the Harvard School of Public Health and has completed a postdoctoral fellowship at the Harvard Medical School Faculty Development Program.